Contrasting BioForce Nanosciences (BFNH) and The Competition

BioForce Nanosciences (OTCMKTS:BFNHGet Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare BioForce Nanosciences to related companies based on the strength of its risk, profitability, valuation, analyst recommendations, dividends, institutional ownership and earnings.

Valuation and Earnings

This table compares BioForce Nanosciences and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
BioForce Nanosciences $20,000.00 -$500,000.00 -205.00
BioForce Nanosciences Competitors $1.19 billion $356.47 million -26.65

BioForce Nanosciences’ competitors have higher revenue and earnings than BioForce Nanosciences. BioForce Nanosciences is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current recommendations for BioForce Nanosciences and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioForce Nanosciences 0 0 0 0 N/A
BioForce Nanosciences Competitors 323 1330 1829 58 2.46

As a group, “Analytical instruments” companies have a potential upside of 26.57%. Given BioForce Nanosciences’ competitors higher possible upside, analysts clearly believe BioForce Nanosciences has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

61.9% of shares of all “Analytical instruments” companies are held by institutional investors. 39.5% of BioForce Nanosciences shares are held by company insiders. Comparatively, 13.0% of shares of all “Analytical instruments” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.


This table compares BioForce Nanosciences and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BioForce Nanosciences N/A N/A -2,538.94%
BioForce Nanosciences Competitors -232.11% 7.13% -10.99%

Volatility & Risk

BioForce Nanosciences has a beta of -1.44, indicating that its share price is 244% less volatile than the S&P 500. Comparatively, BioForce Nanosciences’ competitors have a beta of 1.10, indicating that their average share price is 10% more volatile than the S&P 500.


BioForce Nanosciences competitors beat BioForce Nanosciences on 8 of the 10 factors compared.

BioForce Nanosciences Company Profile (Get Rating)

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.

Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with's FREE daily email newsletter.